📰 Tim Dyer News
Page 4 - Tim Dyer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tim Dyer. Real-time updates on events, politics, business and more.
May 15, 2023
The Morocco National Tourism Office (ONMT) has appointed Miki Travel Asia as its official partner to spearhead the development of sales activities in the Asia
May 10, 2023
Cohort 1 progressing through Part 2Cohort 2 recruiting patients Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex...
May 10, 2023
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric... | May 10, 2023
May 10, 2023
10.05.2023 - Cohort 1 progressing through Part 2Cohort 2 recruiting patients Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric ... Seite 1
May 10, 2023
Cohort 1 progressing through Part 2Cohort 2 recruiting patients Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical... | May 10, 2023
April 5, 2023
Proceeds to advance allosteric modulator therapeutic pipeline Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 5, 2023 - Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN)
April 4, 2023
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 4, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug... | April 4, 2023
February 15, 2023
DENVER--(BUSINESS WIRE)--Cogent Global Solutions today announces the launch of a new Next Level Clinical Presentations (NxLCP) system. The system is designed specifically to address the needs of surgeons communicating new technology revolutionizing modern medicine.Proprietary to Cogent, the NxLCP system accommodates...
January 28, 2023
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 19, 2023 - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based
December 8, 2022
08.12.2022 - Addex to receive USD 1 million in additional research fundingCollaboration continues to advance through drug candidate selection phase Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 8, 2022 - Addex Therapeutics (SIX and ... Seite 1